-
20m 32s
-
25m 18sPart 1 | Session 1 View from the Thoraxcenter – What's Hot at ESC 2021
-
36m 1sPart 1 | Session 2 View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up
-
19m 47sPart 2 | Session 1 ESC 2021 Discussion: The EMPEROR-Preserved Trial
-
15m 2sPart 2 | Session 2 ESC 2021 Discussion: The FIGARO-DKD Trial
-
20m 8sPart 2 | Session 3 ESC 2021 Discussion: The EMPEROR-Pooled Study
-
6m 33s
-
4m 39sPart 3 | Session 2 SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI
-
8m 40sPart 3 | Session 3 TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI
-
5m 21sPart 3 | Session 4 The LAAOS III Study: Surgical AFIB Ablation Evaluation
-
9mPart 3 | Session 5 TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type
-
5m 43sPart 3 | Session 6 STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS
-
5m 41sPart 3 | Session 7 SPLENDOR: Metabolic Surgery and Risk of MACE in NASH
-
5m 11s
-
6m 9sPart 3 | Session 9 VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes
-
5m 50sPart 3 | Session 10 Micra CED: 2-Year Outcomes with Leadless Pacing
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science results and spotlight impactful data.
For a deeper dive into key clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series.
Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Faculty Biographies
Nick Curzen
Professor of Interventional Cardiology & Consultant Cardiologist
Prof Nick Curzen (BM (hons) PhD FRCP) is a Professor of Interventional Cardiology at the University of Southampton and Honorary Consultant Cardiologist at the University Hospital Southampton NHS Foundation Trust. Prof Curzen served as President of the British Cardiovascular Intervention Society (BCIS) until the end of his tenure in January 2023.
He pursues an active research programme: Chief Investigator for RIPCORD2 and FORECAST randomised trials as well as for FFRCT RIPCORD & COMET. He also has active interests in platelet function, computer modelling of coronary stents and re-do TAVI implantation and coronary physiology. The research group contributes to many high-profile multicentre trials. Nick has published over 320 PubMed papers and has edited 3 textbooks, including the Oxford Textbook of Interventional Cardiology.
Prof Nick Curzen is an editorial board member of Interventional Cardiology: Reviews, Research,…